scholarly article | Q13442814 |
P2093 | author name string | Kwang-Il Kim | |
Mi Na Kim | |||
Kyu Sung Rim | |||
Seong Gyu Hwang | |||
Hana Park | |||
Soo-Hwan Kim | |||
Joo Ho Lee | |||
Young Eun Chon | |||
Yeonjung Ha | |||
Yun Bin Lee | |||
P2860 | cites work | Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients. | Q51353878 |
The natural history of chronic hepatitis B virus infection | Q64133519 | ||
Hepatitis B virus infection | Q88131866 | ||
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man | Q26776977 | ||
Management of hepatocellular carcinoma: An update | Q27860530 | ||
2014 Korean Liver Cancer Study Group-National Cancer Center Korea practice guideline for the management of hepatocellular carcinoma | Q28394414 | ||
Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies | Q29614505 | ||
Design and validation of a histological scoring system for nonalcoholic fatty liver disease | Q29614930 | ||
Management of hepatocellular carcinoma | Q29616230 | ||
Histological grading and staging of chronic hepatitis | Q29619625 | ||
Concurrent fatty liver increases risk of hepatocellular carcinoma among patients with chronic hepatitis B. | Q30392056 | ||
Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. | Q30984322 | ||
Liver biopsy | Q33932981 | ||
The clinicopathologic spectrum and management of nonalcoholic fatty liver disease | Q34470464 | ||
The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis | Q34617479 | ||
AGA technical review on nonalcoholic fatty liver disease | Q34982453 | ||
Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; Internat | Q35006662 | ||
Hepatitis B e antigen-negative chronic hepatitis B: natural history and treatment | Q36467970 | ||
KASL clinical practice guidelines: management of nonalcoholic fatty liver disease | Q37488800 | ||
The Diagnosis and Management of Nonalcoholic Fatty Liver Disease: Practice Guidance from the American Association for the Study of Liver Diseases. | Q38676257 | ||
Influence of Metabolic Risk Factors on Risk of Hepatocellular Carcinoma and Liver-related Death in Men with Chronic Hepatitis B: A Large Cohort Study. | Q38677390 | ||
Hepatitis B virus. The major etiology of hepatocellular carcinoma | Q39199064 | ||
Hepatic steatosis is highly prevalent in hepatitis B patients and negatively associated with virological factors | Q42218044 | ||
Utility and appropriateness of the fatty liver inhibition of progression (FLIP) algorithm and steatosis, activity, and fibrosis (SAF) score in the evaluation of biopsies of nonalcoholic fatty liver disease | Q44227516 | ||
Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection: a follow-up study in Taiwan. | Q46573520 | ||
Practice guidelines for management of hepatocellular carcinoma 2009 | Q50247644 | ||
P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | hepatocellular carcinoma | Q1148337 |
steatosis | Q1365091 | ||
chronic hepatitis B | Q55779876 | ||
P304 | page(s) | 52-64 | |
P577 | publication date | 2018-10-23 | |
P1433 | published in | Clinical and molecular hepatology | Q26853927 |
P1476 | title | Association between hepatic steatosis and the development of hepatocellular carcinoma in patients with chronic hepatitis B | |
P478 | volume | 25 |
Q92841191 | Abnormal CD44 activation of hepatocytes with nonalcoholic fatty accumulation in rat hepatocarcinogenesis | cites work | P2860 |
Search more.